About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Bilateral Peroneal Axonal Neuropathy: A Rare Post-malarial Neurological Syndrome

lexapro pregnancy class

lexapro and pregnancy
Nikhil Gupta, Nishant Singh1, Sarthak Malik
From the Department of Medicine, University College of Medical Sciences & GTB Hospital, Dilshad Garden & Maulana Azad Medical College1, Bahadur Shah Zafar Marg, University of Delhi,
Delhi, India.
Corresponding Author:
Dr. Nikhil Gupta
Email: nik.gupta4u@gmail.com
Received: 12-JUL-2013 Accepted: 25-OCT-2013 Published Online: 30-NOV-2013
DOI: http://dx.doi.org/10.17659/01.2013.0099
Abstract
Malaria still remains a leading cause of morbidity and mortality in humans despite intensive efforts from government and sanitary bodies to control malaria. Common presentations of malaria include intermittent fever with chills and rigors, jaundice, renal failure, myalgia etc. In endemic regions, malaria can present with unusual features due to development of immunity, indiscriminate use of antimalarial drugs and increasing resistance to antimalarial drugs. Post malaria neurological syndrome has been described in literature as a rare complication of malaria. To our knowledge, bilateral peroneal axonal neuropathy as a post malaria neurological syndrome is an undescribed entity. We report an unusual and a rare presentation of falciparum malaria.
Keywords : Malaria, Falciparum Malaria, Renal Insufficiency, Myalgia, Jaundice.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025